Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1889252 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Nerve Growth Factor Receptor (NGFR) (C-Term), (AA 397-414) antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide corresponding to a sequence at the C-terminus of human p75 NGF Receptor(AA 397-414 TLDALLAALRRIQRADLV), different from the related mouse and rat sequences by one amino acid.
- Description
- Immunogen affinity purified.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Epitope
- C-Term,AA 397-414
- Isotype
- IgG
- Vial size
- 100 μg
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid repeated freezing and thawing.
- Handling
- Avoid repeated freezing and thawing.
Submitted references p75(NTR) mediates ephrin-A reverse signaling required for axon repulsion and mapping.
The neurotrophin receptor p75NTR modulates long-term depression and regulates the expression of AMPA receptor subunits in the hippocampus.
Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor.
Lim YS, McLaughlin T, Sung TC, Santiago A, Lee KF, O'Leary DD
Neuron 2008 Sep 11;59(5):746-58
Neuron 2008 Sep 11;59(5):746-58
The neurotrophin receptor p75NTR modulates long-term depression and regulates the expression of AMPA receptor subunits in the hippocampus.
Rösch H, Schweigreiter R, Bonhoeffer T, Barde YA, Korte M
Proceedings of the National Academy of Sciences of the United States of America 2005 May 17;102(20):7362-7
Proceedings of the National Academy of Sciences of the United States of America 2005 May 17;102(20):7362-7
Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor.
Dobrowsky RT, Werner MH, Castellino AM, Chao MV, Hannun YA
Science (New York, N.Y.) 1994 Sep 9;265(5178):1596-9
Science (New York, N.Y.) 1994 Sep 9;265(5178):1596-9
No comments: Submit comment
No validations: Submit validation data